Health In Tech Announces Third Quarter 2025 Financial Results

Rhea-AI Summary

Health In Tech (NASDAQ: HIT) reported third-quarter 2025 results with revenue of $8.5M (up 90% YoY) and nine-month revenue of $25.8M (132% of full-year 2024). Adjusted EBITDA was $1.0M (up 49% YoY) and nine-month adjusted EBITDA was $3.8M (167% of full-year 2024). Pre-tax income for Q3 was $0.6M (up 48% YoY). Billed enrolled employees reached 25,248 and distribution partners rose to 849 (up 57% YoY). Cash was $8.0M and accounts receivable were $0.9M as of September 30, 2025.

Operational highlights include an eDIYBS upgrade enabling large-employer quoting for 150+ employee groups in about two weeks and a non-binding LOI with AlphaTON Capital to explore a blockchain claims platform, HITChain.

Positive

• Revenue +90% year-over-year to $8.5M in Q3 2025
• Nine-month revenue $25.8M, 132% of full-year 2024
• Adjusted EBITDA +49% year-over-year to $1.0M in Q3 2025
• Distribution partners expanded to 849, +57% year-over-year
• Large-group underwriting for 150+ employees in ~2 weeks

Negative

• None.

Insights

Senior Financial Analyst

Strong top‑line and margin improvement this quarter; growth appears operational and distribution‑led.

Revenue rose to $8.5 million in Q3, up 90% year‑over‑year, with nine‑month revenue of $25.8 million (already 132% of full‑year 2024). Adjusted EBITDA increased to $1.0 million (up 49% YoY) and nine‑month adjusted EBITDA reached $3.8 million (or 167% of full‑year 2024). The company reports billed enrolled employees of 25,248 (an increase of 7,654 YoY) and partner count of 849 (up 57% YoY), which connects the revenue gains to measurable distribution expansion.

Key dependencies and risks include conversion of expanded distribution into sustained margins and effective receivables management; cash of $8.0 million and accounts receivable, net of $0.9 million are relevant liquidity signals but do not alone define runway. The LOI to explore a blockchain claims platform and the eDIYBS upgrade to serve 150+ employee groups are strategic extensions of product scope, but the LOI is non‑binding and the timeline or economics of HITChain are not specified.

Monitor near‑term milestone dates and metrics: the conference call on Nov 10, 2025, quarterly revenue and adjusted EBITDA trends, billed enrolled employees and partner growth, cash and accounts receivable changes, and any firm agreement or pilots for HITChain. Over the next 12 months, watch whether the large‑employer underwriting capability materially expands average contract size and whether the LOI converts into binding contracts or pilot launches that produce measurable cost or revenue impact.

• Revenue reached $8.5 million, up 90% year over year; nine-month revenue totaled $25.8 million, representing 132% of full-year 2024 total revenue.
• Adjusted EBITDA was $1.0 million, an increase of 49% year over year; nine-month adjusted EBITDA reached $3.8 million, or 167% of full-year 2024 total.

STUART, Fla., Nov. 10, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the third quarter ended September 30, 2025.

Financial Highlights for the Third Quarter and Nine-Month of 2025:

• Billed Enrolled Employees. The number of billed enrolled employees (EEs) was 25,248, an increase of 7,654 EEs YoY.
• Distribution. The number of Brokers, Third-party Administrator ("TPAs") and Agencies expanded to 849 partners as of September 30, 2025, up 57% YoY.
• Revenues. Total revenues were $8.5 million, up 90% YoY; The first-nine months revenues of $25.8 million, 132% of full year 2024.
• Pre-tax income. Pre-tax income was $0.6 million, up 48% YoY; The first-nine months pre-tax income of $2.1 million, 238% of full year 2024.
• Adjusted EBITDA. Adjusted EBITDA was $1.0 million, up 49% YoY; The first-nine months adjusted EBITDA of $3.8 million, 167% of full year 2024.
• Cash. Cash balance was $8.0 million as of September 30, 2025.
• Accounts receivable, net. Accounts receivable balance was $0.9 million as of September 30, 2025, reduced $0.1 million YoY.

Tim Johnson, CEO of Health In Tech, said:
"Our third quarter highlights the accelerating strength of our distribution ecosystem and the solid foundation we've built this year. Revenue reached $8.5 million, up 90% year over year, bringing nine-month revenue to $25.8 million—already 132% of full-year 2024 revenue. This growth reflects the continued expansion of our broker, TPA, and agency network, which is now translating directly into sustained revenue momentum as our technology gains adoption across new distribution channels."

He continued:
"In September, we launched large-employer underwriting within eDIYBS, allowing brokers to generate quotes for groups of 150 or more employees in as little as two weeks—versus the industry timeline of often three months. This capability is a significant milestone, extending the speed and scalability of our small-business underwriting into the mid- and large-employer market. It marks a major step forward in how health plans are designed, quoted, and delivered at scale."

Mr. Johnson added:
"We also remain focused on solving one of the most costly inefficiencies in U.S. healthcare—claims administration, which costs the industry more than $300 billion annually. Our non-binding LOI with AlphaTON Capital marks a strategic step toward exploring blockchain-enabled solutions that can modernize this process. Together with AlphaTON and Brittany Kaiser's leadership in blockchain ethics and policy, we're developing HITChain—a decentralized, verifiable claims infrastructure designed to compress processing timelines, eliminate duplication, lower costs, and create a transparent system of record for all stakeholders.

By combining insurance domain expertise with blockchain innovation, we're seeking to position Health In Tech at the frontier of decentralized healthcare infrastructure—a market opportunity of substantial scale and long-term impact."

"We delivered another quarter of strong financial performance," said Julia Qian, CFO of Health In Tech. "Revenue grew 90% year over year and profit increased 48%, reflecting both operational strength and disciplined execution. We continue to balance growth with strategic investments in technology and enhanced platform capabilities—initiatives that reinforce our leadership position and support sustainable long-term performance."

Recent Business Developments and Highlights

• eDIYBS Upgrade: Expanded HIT's Enhanced Do-It-Yourself Benefit System to serve 150+ employee groups. This upgrade significantly increases HIT's addressable market and accelerates large-group underwriting from months to about 2 weeks, extending the speed and scalability of our small-business underwriting into the mid- and large-employer market. It marks a major step forward in how health plans are designed, quoted, and delivered at scale.
  
  
• AlphaTON Capital: Signed a non-binding strategic LOI to co-develop HITChain, a blockchain-powered claims platform built on The Open Network (TON). The partnership positions HIT at the forefront of decentralized claims infrastructure, targeting efficiency gains in the $300B+ U.S. claims market.
  
  
• 2026 Davos Summit: Announced to host HIT's first Independent InsurTech Summit during the World Economic Forum week in Davos. The event will convene global leaders across insurance, healthcare, and technology. Two panels have been announced this quarter: "AI and Institutional Resistance - CEOs Driving Change in Legacy Sectors," featuring TIME CEO Jessica Sibley and HIT CEO Tim Johnson; and "First Ladies: Backing Women Who Build" featuring Cherie Blair CBE, KC, Founder of the Cherie Blair Foundation for Women. Additional panels will be announced in the coming months, highlighting HIT's expanding influence in shaping global industry dialogue.
  
  
• SIIA 2025 Conference: Showcased upgraded eDIYBS to thousands of industry leaders. The event expanded broker engagement and reinforced HIT's reputation as a leader in AI-powered self-funding solutions, demonstrating real-time quoting capabilities and platform flexibility.

Conference Call Details

Health In Tech will host a conference call to discuss the financial results for the Third quarter of 2025 on Nov 10, 2025, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).

A live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

Non-GAAP Financial Information

This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

Use of Forward ‑ Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

About Health In Tech 

Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

 

Health In Tech, Inc.
Consolidated Statements of Operations
（ Unaudited ）
		Three Months Ended September 30,			Nine Months Ended  September 30,
		2025		2024		2025		2024
Revenues
Revenues from underwriting     modeling (ICE)		$1,389,604		$1,528,451		$5,832,164		$4,952,191
Revenues from fees		7,100,489		2,930,470		19,986,762		9,634,151
SMR		7,100,489		2,250,549		19,986,762		7,379,016
HI Card		-		679,921		-		2,255,135
Total revenues		8,490,093		4,458,921		25,818,926		14,586,342
Cost of revenues		3,346,277		979,628		9,009,841		2,944,266
Gross profit		5,143,816		3,479,293		16,809,085		11,642,076
Operating expenses
Sales and marketing expenses		962,567		508,467		3,279,560		2,526,197
General and administrative expenses		3,451,907		1,813,520		10,474,125		5,629,393
Research and development  expenses		235,819		718,424		1,356,149		2,180,246
Total operating expenses		4,650,293		3,040,411		15,109,834		10,335,836
Other income (expense):
Interest income		111,699		38,460		305,263		94,111
Interest expenses		-		(165,000)		-		(495,000)
Other income		-		157,156		118,399		157,156
Other expense		(5,000)		(62,759)		(5,000)		(62,759)
Total other income (expense), net		106,699		(32,143)		418,662		(306,492)
Income before income tax expense		$600,222		$406,739		$2,117,913		$999,748
Provision for income taxes		(148,046)		(30,653)		(536,514)		(185,119)
Net income		$452,176		$376,086		$1,581,399		$814,629
Net income per share
Basic		$0.01		$0.01		$0.03		$0.02
Diluted		$0.01		$0.01		$0.03		$0.02
Weighted average common stocks outstanding
Basic		56,432,407		51,769,358		55,484,860		51,769,358
Diluted		58,774,334		51,769,358		57,477,873		51,769,358

 

Health In Tech, Inc.
Consolidated Balance Sheets
(Unaudited)
		September 30, 2025		December 31, 2024
Assets
Current assets
Cash		$8,023,613		$7,849,248
Accounts receivable, net		868,628		1,647,103
Other receivables		3,871,106		500,252
Deferred offering costs		166,012		-
Prepaid expenses and other current assets		2,117,854		787,161
Total current assets		15,047,213		10,783,764
Non-current assets
Software		6,182,691		3,962,461
Loans receivable, net		863,996		815,995
Operating lease - right of use assets		157,122		206,269
Long-term prepaid expenses		504,822		-
Total non-current assets		7,708,631		4,984,725
Total assets		$22,755,844		$15,768,489
Liabilities and stockholders' equity
Current liabilities
Accounts payable and accrued expenses		$4,295,384		$1,858,840
Income taxes payable		-		205,253
Operating lease liabilities - current		73,769		66,881
Other current liabilities		869,088		-
Total current liabilities		5,238,241		2,130,974
Non-current liabilities
Deferred tax liabilities		274,809		328,676
Operating lease liabilities - non-current		83,831		139,811
Total non-current liabilities		358,640		468,487
Total liabilities		5,596,881		2,599,461
Stockholders' equity
Common stock, $0.001 par value; Class A Common         stock 150,000,000 shares authorized, 44,785,771        and 42,914,870 shares issued and outstanding as of      September 30, 2025 and December 31, 2024,        respectively		44,785		42,915
Common stock, $0.001 par value; Class B Common      stock 50,000,000 shares authorized, 11,700,000      shares issued and outstanding as of September 30,         2025 and December 31, 2024, respectively		11,700		11,700
Additional paid-in capital		11,579,683		9,173,017
Retained earnings		5,522,795		3,941,396
Total stockholders' equity		17,158,963		13,169,028
Total liabilities and stockholders' equity		$22,755,844		$15,768,489

 

Health In Tech, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
		Three Months Ended September 30,				Nine Months Ended September 30,
		2025		2024		2025		2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		$452,176		$376,086		$1,581,399		$814,629
Adjustments to reconcile net income to net cash provided by operating activities:
Write-off of accounts receivable		(4,089)		-		1,901		-
Amortization expense		217,981		135,584		489,947		405,158
Provision for refund liability		1,413,345		-		2,369,088		-
Deferred tax expenses (benefits)		12,680		(27,676)		(53,867)		(86,992)
Amortization of debt discount		-		165,000		-		495,000
Interest income		(16,003)		(15,999)		(48,001)		(47,997)
Stock-based compensation expense		292,552		-		1,493,686		-
Changes in operating assets and     liabilities:
Accounts receivable, net		416,592		524,838		776,574		1,302,733
Other receivables		(16,272)		546,645		(3,370,854)		1,166,017
Prepaid expenses and other current  assets		(486,424)		(118,116)		(690,665)		(209,841)
Long-term prepaid expenses		151,000		-		(206,666)		-
Operating lease right of use assets           and liabilities, net		18		624		55		1,871
Accounts payable and accrued  expenses		(224,639)		491,031		2,045,258		(1,064,527)
Income taxes payable		(34,944)		43,030		(205,253)		(68,675)
Other current liabilities		(1,500,000)		-		(1,500,000)		-
Net cash provided by operating activities		673,973		2,121,047		2,682,602		2,707,376
CASH FLOWS FROM INVESTING ACTIVITIES:
Development of software		(744,841)		(67,278)		(2,358,213)		(294,634)
Net cash used in investing activities		(744,841)		(67,278)		(2,358,213)		(294,634)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of deferred offering costs		(43,685)		(324,744)		(150,024)		(936,864)
Repayments of notes payable		-		(2,145,000)		-		(2,145,000)
Net cash used in  financing activities		(43,685)		(2,469,744)		(150,024)		(3,081,864)
Increase (decrease) in cash		(114,553)		(415,975)		174,365		(669,122)
Cash, beginning of the period		8,138,166		2,163,203		7,849,248		2,416,350
Cash, end of the period		8,023,613		1,747,228		8,023,613		1,747,228
Supplemental disclosures of cash flow information:
Cash paid for interest		$-		$-		$-		$-
Cash paid for income taxes		$198,000		$15,300		$823,323		$340,787
Summary of noncash investing and financing activities:
Accrued deferred offering costs included in accounts payable and accrued expenses		$55,827		$137,325		$55,827		$137,325
Accrued development of software included in accounts payable and accrued expenses		$401,964		$126,977		$401,964		$126,977
Issuance of Class A common stock for future  service		$146,816		$-		$1,184,800		$-

 

Adjusted EBITDA Reconciliation
(Unaudited)
		For Three Months Ended September 30,				For Nine Months Ended September 30,
		2025		2024		2025		2024
Net income		$452,176		$376,086		$1,581,399		$814,629
Interest (income) expenses		(111,699)		126,540		(305,263)		400,889
Depreciation and amortization		217,981		135,584		489,947		405,158
Income tax expense		148,046		30,653		536,514		185,119
Stock-based compensation expense		292,552		-		1,493,686		-
Total net adjustments		546,880		292,777		2,214,884		991,166
Adjusted EBITDA		$999,056		$668,863		$3,796,283		$1,805,795

Components of Operating Results

Revenues

While we generate our revenue primarily from small employers and insurance carriers, we grow our business primarily from offering solutions that streamline sales processes, enhance service delivery, and reduce the sales cycle duration for TPAs, MGUs, and Brokers. We offer our services through our three subsidiaries. Program services provided by SMR and MGU activities provided by ICE (including eDIYBS) are interdependent, as they cannot function effectively without being combined. Services provided by HI Card are an optional add-on to our other services, and cannot be offered on a standalone basis. Brokers that utilize the program services on behalf of the small employer provided by SMR and MGU activities provided by ICE, are not obligated to utilize our HI Card service. Currently ICE does not offer underwriting services as a standalone service. In the future, we may consider offering it as a standalone service.

Cost of revenues

Cost of revenues primarily consists of infrastructure costs to operate our platform such as hosting fees and fees paid to various third-party partners for access to their technology, services and amortization expenses of our capitalized internal-use software related to our platform. We mainly outsource captive management services and data services from the third-party companies. Our internal proprietary system seeks to consistently improve underwriting and services results through machine learning and data feeds. The captive management activities include introducing new carriers, conducting due diligence on carriers, conducting feasibility studies to determine the viability to be a stop-loss carrier on the platform, negotiating terms and contracts, coordinating audit requests, managing relationship with unrelated carriers and their regulators and auditor firms to ensure that our risk associated with our service offerings is minimized.

Sales and marketing expenses

Sales and marketing expenses primarily consist of personnel-related costs including salaries, stock-based compensation expense, benefits and commissions cost for our sales and marketing personnel. Sales and marketing expenses also include the costs for advertising, promotional and other marketing activities, as well as certain fees paid to various third-party for sales and customer acquisition.

General and administrative expenses

General and administrative expenses primarily consist of personnel-related costs and related expenses for our executives, finance, legal, human resources, technical support, and administrative personnel as well as the costs associated with professional fees for external legal, accounting and other consulting services, insurance premiums.

Research and development expenses

Research and development expenses primarily consist of personnel-related costs, including salaries, stock-based compensation expense and benefits for our research and development personnel. Additional expenses include costs related to the software development, quality assurance, and testing of new technology, and enhancement of our existing platform technology.

Adjusted EBITDA

Adjusted EBITDA represents our net income before net interest expense, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA, and we believe this approach provides a more meaningful measure by offering a clearer view of our underlying operational performance.

 

Financial Results Summary
(Unaudited ）
($ in millions)
	Three Months Ended September 30,								Nine Months Ended September 30,
		2025			2024		% Change			2025			2024		% Change
Total revenues	$	8.5		$	4.5		90.4 %		$	25.8		$	14.6		77.0 %
GAAP gross margin		60.6 %			78.0 %		-17.4 %		$	65.1 %		$	79.8 %		-14.7 %
Income before income tax expense	$	0.6		$	0.4		47.6 %		$	2.1		$	1.0		111.8 %
Adjusted EBITDA	$	1.0		$	0.7		49.4 %		$	3.8		$	1.8		110.2 %

Investor Contact
Investor Relations:
ir@healthintech.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-third-quarter-2025-financial-results-302610172.html

SOURCE Health In Tech

FAQ

What were Health In Tech (HIT) Q3 2025 revenues and growth rate?

Q3 2025 revenue was $8.5 million, up 90% year-over-year.

How much revenue did HIT generate in the first nine months of 2025?

Nine-month 2025 revenue was $25.8 million, equal to 132% of full-year 2024.

What was Health In Tech's adjusted EBITDA for Q3 2025 and year-over-year change?

Adjusted EBITDA for Q3 2025 was $1.0 million, a 49% increase year-over-year.

How many distribution partners and billed enrolled employees did HIT report for Q3 2025?

HIT reported 849 brokers/TPAs/agencies and 25,248 billed enrolled employees as of Sept 30, 2025.

What operational product upgrade did HIT announce in Q3 2025?

HIT upgraded eDIYBS to support large-employer quoting (150+ employees) with underwriting in about two weeks.

What is the AlphaTON Capital agreement mentioned by HIT (HIT)?

HIT signed a non-binding LOI with AlphaTON Capital to explore co-developing HITChain, a blockchain claims platform.